Since September 2010, Reverse Rett has consistently made quarterly contributions to the International Research Portfolio at RSRT, contributions now totalling over $6 million.
Our UK work has a translational impact with clear patient benefits. We work to ensure that as treatments and a cure for Rett Syndrome become viable, they are accessible to patients in the UK.
Based in Manchester, we are a small team working double time with minimal bureaucracy.
We believe that to develop treatments and a cure as quickly as possible, the funds we raise need to push research forward today.
That’s why we deliberately hold no endowment or excessive reserves, instead seeking to deploy funds raised as quickly and wisely as possible. Donor contributions are typically deployed to research projects within three months or less.